Article
A novel sustained release therapy of combined VEGF and TNF-α inhibitors leads to…
medRxiv · 2023 · Chengxin Zhou
Key facts
| Title | A novel sustained release therapy of combined VEGF and TNF-α inhibitors leads to pan-ocular protection for months after severe ocular trauma |
|---|---|
| First author | Chengxin Zhou |
| Journal | medRxiv |
| Published | Mar 19, 2023 |
| DOI | 10.1101/2023.03.14.531626 |
| Devices mentioned | K022128, K024289, K053124, K071043, K071266, K073184, K151394, K171404, K173089, K173365, K180319, K181627 and 25 more |
| Product codes mentioned | EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQD, HQF, KKX, LKB and 4 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1